| Autor: |
Beelen, Karin, Opdam, Mark, Tesa Severson, Koornstra, Rutger, Vincent, Andrew, Wesseling, Jelle, Sanders, Joyce, Vermorken, Jan, Diest, Paul Van, Linn, Sabine |
| Rok vydání: |
2018 |
| DOI: |
10.6084/m9.figshare.6859181.v1 |
| Popis: |
Table S1: Distribution of clinico-pathological variables between patients with sufficient tumor material for biomarker analysis and the total group of patients who entered the study patients with sufficient tumor material. Table S2: Inter-observer variability for Ki67 and cyclin D1 immunohistochemistry scores antibody scoring system comparable cores. Table S3: Specifications of REMARK recommendations. Table S4: Multivariate Cox proportional hazard model of recurrence free interval (RFI) including mitotic count and treatment interaction, follow up truncated at 6Â years. Table S5: Multivariate Cox proportional hazard model of recurrence free interval (RFI) including mitotic count and treatment interaction, follow up truncated at 6Â years in HER2 negative patients. Table S6: Multivariate Cox proportional hazard model of recurrence free interval (RFI) including CCND1 copy number ratio and treatment interaction. Table S7a: Interaction tests between tamoxifen and EMSY probe sets analyzed as continuous. Table S7b: Interaction tests between tamoxifen and EMSY probe sets analyzed as binary factor. (PDF 368 kb) |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
